Most carnitine supplements promise fat loss and deliver very little. A 2009 study in the Journal of the International Society of Sports Nutrition tested a different form, glycine propionyl-L-carnitine (GPLC), on something more relevant to lifters and field athletes: repeated all-out sprints. The result was higher power output and lower blood lactate. The headline number is real, but it needs context.
The Study: What Was Actually Done
Researchers at Florida Atlantic University, led by Jacobs, ran a double-blind, placebo-controlled, crossover trial in 24 resistance-trained men (average age 25.2 ± 3.6 years). Each man completed two test sessions one week apart. Ninety minutes before each session, he took either 4.5 g of GPLC or 4.5 g of cellulose as a placebo, in randomized order.
The test was brutal. Each session used five 10-second Wingate cycle sprints separated by 1-minute active recovery periods. The team tracked peak power, mean power, percent power decrement, heart rate and blood lactate before, during and after the sprints. Power was standardized to body mass.
The Numbers: Where the "15%" Comes From
With GPLC, peak and mean power were 2.6% to 15% greater across the five sprint bouts (significant main effect of condition, p < 0.05). That range matters. The 15% figure is the top of the range, not the average boost in every sprint. The researchers also found significant interactions between bout order and condition for both peak and mean power (p < 0.05). So the size of the benefit changed from sprint to sprint.
The abstract does not say which bouts showed the largest and smallest gains. Check the full paper before assuming GPLC mostly helps late fatigued sprints, or early ones.
Lactate told a similar story, with one caveat:
- 4 minutes post-exercise: lactate was 15.7% lower with GPLC, but the abstract lists p = 0.09. That is not statistically significant by the usual p < 0.05 cutoff.
- 14 minutes post-exercise: lactate was 16.2% lower with GPLC (p < 0.05).
The paper reports a significant main effect of condition for lactate overall, but the cleanest individual result is the 14-minute value.
GPLC vs. Regular L-Carnitine vs. ALCAR
All three are built around carnitine, the compound that helps shuttle fatty acids into mitochondria. They differ in what is attached:
- L-carnitine is the plain form, usually sold for fat metabolism and general support.
- Acetyl-L-carnitine (ALCAR) has an acetyl group and is mostly marketed for cognitive and nervous system support.
- GPLC is propionyl-L-carnitine bound to glycine. Propionyl-L-carnitine has been studied in vascular contexts, which brings us to nitric oxide.
The study's background notes that earlier research found short-term GPLC raised nitric oxide metabolites at rest and in response to reactive hyperaemia (the blood-flow surge after temporary restriction). Nitric oxide widens blood vessels, so the idea is that better blood flow could help delivery and clearance during repeated efforts. That is a plausible hypothesis, but this study did not measure nitric oxide or blood flow. It shows performance and lactate changed, not why. Treat the mechanism as a theory.
Limits You Should Know About
This is promising, not settled.
- Small sample: 24 young, resistance-trained men. Results may not carry over to women, older adults, endurance athletes or beginners.
- One acute dose: this tested a single 4.5 g dose, not weeks of daily supplementation.
- One exercise mode: stationary cycle Wingate sprints. Whether it helps barbell work, running sprints or team sports is unknown.
- Single lab, limited replication: one research group produced these results, and independent replication is thin. Check the full paper's funding and conflict-of-interest disclosures, as you should with any supplement study.
- A mixed lactate signal: one of the two lactate comparisons missed significance.
- Lower lactate is not automatically better performance. It may reflect less glycolytic stress or faster clearance. The study can't say which.
What This Means for You
Dose and timing (as tested): 4.5 g taken about 90 minutes before training. That is the only protocol with data here. Don't assume smaller doses or different timing give the same effect.
Who it might suit:
- Athletes doing HIIT, sprint intervals or repeated-effort sessions with short rests
- Resistance-trained people who want to experiment with a pre-workout aid for conditioning days
- Anyone who accepts the evidence is early and wants to test it carefully
Who should probably skip it:
- Anyone hoping for a fat-loss or general-health fix. This study doesn't address that.
- People with kidney disease, thyroid conditions, seizure disorders or on prescription medication, who should talk to a clinician before taking any carnitine product
- Anyone who is pregnant or nursing
- Budget-conscious lifters. A 4.5 g dose is large compared with typical serving sizes on many carnitine products, so costs add up. Compare per-gram prices and confirm the label actually lists GPLC content.
A sensible way to test it: try it on a hard interval day and track repeat sprint output and perceived recovery against a comparable session without it. Keep everything else, including food, caffeine and sleep, constant. A personal trial is anecdotal, but it beats guessing.
Bottom Line
In this crossover trial, a single 4.5 g dose of GPLC raised sprint power by 2.6% to 15% across five bouts and lowered lactate 14 minutes after exercise by 16.2%. That is interesting for sprint and interval athletes. But it is one small, acute, single-lab study on cycling, and the nitric oxide explanation is untested here. GPLC deserves more research, not blind faith.
